Teschke Rolf, Danan Gaby
Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/ Main, D-63450 Hanau, Germany.
Pharmacovigilance Consultancy, F-75020 Paris, France.
Diagnostics (Basel). 2021 Mar 6;11(3):458. doi: 10.3390/diagnostics11030458.
Causality assessment in liver injury induced by drugs and herbs remains a debated issue, requiring innovation and thorough understanding based on detailed information. Artificial intelligence (AI) principles recommend the use of algorithms for solving complex processes and are included in the diagnostic algorithm of Roussel Uclaf Causality Assessment Method (RUCAM) to help assess causality in suspected cases of idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI). From 1993 until the middle of 2020, a total of 95,865 DILI and HILI cases were assessed by RUCAM, outperforming by case numbers any other causality assessment method. The success of RUCAM can be traced back to its quantitative features with specific data elements that are individually scored leading to a final causality grading. RUCAM is objective, user friendly, transparent, and liver injury specific, with an updated version that should be used in future DILI and HILI cases. Support of RUCAM was also provided by scientists from China, not affiliated to any network, in the results of a scientometric evaluation of the global knowledge base of DILI. They highlighted the original RUCAM of 1993 and their authors as a publication quoted the greatest number of times and ranked first in the category of the top 10 references related to DILI. In conclusion, for stakeholders involved in DILI and HILI, RUCAM seems to be an effective diagnostic algorithm in line with AI principles.
药物和草药所致肝损伤的因果关系评估仍是一个存在争议的问题,需要在详细信息的基础上进行创新并深入理解。人工智能(AI)原理建议使用算法来解决复杂过程,并被纳入到罗塞尔·优克福因果关系评估方法(RUCAM)的诊断算法中,以帮助评估疑似特异质性药物性肝损伤(DILI)和草药性肝损伤(HILI)病例的因果关系。从1993年到2020年年中,RUCAM共评估了95865例DILI和HILI病例,在病例数量上超过了任何其他因果关系评估方法。RUCAM的成功可追溯到其具有定量特征,通过对特定数据元素进行单独评分,从而得出最终的因果关系分级。RUCAM客观、用户友好、透明且针对肝损伤,其更新版本应在未来的DILI和HILI病例中使用。来自中国且不属于任何网络的科学家在对DILI全球知识库的科学计量学评估结果中也提供了对RUCAM的支持。他们强调1993年的原始RUCAM及其作者是被引用次数最多的出版物,在与DILI相关的前10篇参考文献类别中排名第一。总之,对于参与DILI和HILI的利益相关者而言,RUCAM似乎是一种符合AI原理的有效诊断算法。